Drug
DCR-PHXC
DCR-PHXC is a pharmaceutical drug with 5 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
2(40%)
Results Posted
33%(1 trials)
Phase Distribution
Ph phase_2
2
40%
Ph phase_3
1
20%
Ph phase_1
2
40%
Phase Distribution
2
Early Stage
2
Mid Stage
1
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
2(40.0%)
Phase 2Efficacy & side effects
2(40.0%)
Phase 3Large-scale testing
1(20.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
5
all time
Status Distribution
Active(2)
Completed(3)
Detailed Status
Completed3
Active, not recruiting1
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
2
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 12 (40.0%)
Phase 22 (40.0%)
Phase 31 (20.0%)
Trials by Status
active_not_recruiting120%
recruiting120%
completed360%
Recent Activity
2 active trials
Showing 5 of 5
recruitingphase_2
Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD
NCT04580420
active_not_recruitingphase_3
Long Term Extension Study in Patients With Primary Hyperoxaluria
NCT04042402
completedphase_1
Study to Evaluate Safety, Tolerability, PK and PD of DCR-PHXC in PH Type 3 Patients
NCT04555486
completedphase_1
Study of DCR-PHXC-101 in Normal Healthy Volunteers and Patients With Primary Hyperoxaluria
NCT03392896
completedphase_2
A Study to Evaluate DCR-PHXC in Children and Adults With Primary Hyperoxaluria Type 1 and Primary Hyperoxaluria Type 2
NCT03847909
Clinical Trials (5)
Showing 5 of 5 trials
NCT04580420Phase 2
Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD
NCT04042402Phase 3
Long Term Extension Study in Patients With Primary Hyperoxaluria
NCT04555486Phase 1
Study to Evaluate Safety, Tolerability, PK and PD of DCR-PHXC in PH Type 3 Patients
NCT03392896Phase 1
Study of DCR-PHXC-101 in Normal Healthy Volunteers and Patients With Primary Hyperoxaluria
NCT03847909Phase 2
A Study to Evaluate DCR-PHXC in Children and Adults With Primary Hyperoxaluria Type 1 and Primary Hyperoxaluria Type 2
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5